🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 8 of 15

  1. US 10207993

    Compounds as anti-tubercular agents

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10196403

    Compounds and compositions and uses thereof

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10189784

    N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10189825

    Heteroaryl compounds and methods of use thereof

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10183915

    Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10173989

    1,2,4-oxadiazole derivatives as immunomodulators

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10174018

    Protein kinase inhibitors

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10160736

    1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10160753

    Indazole compounds as IRAK4 inhibitors

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10155936

    Parkin ligase activation methods and compositions

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10130677

    Antimicrobial peptide and uses thereof

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10131701

    Human leucine zipper/trail recombinant polypeptides

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10123989

    Method of lowering cholesterol

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10118902

    Small molecule agonists of neurotensin receptor 1

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10106581

    Cyclic peptidomimetic compounds as immunomodulators

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10106538

    Inhibitors of protein kinases

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10098887

    Antiviral compounds and methods of use thereof

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10100012

    Compounds as anti-tubercular agents

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10093686

    Heteroaryl inhibitors of PDE4

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10087156

    Methods and compositions related to retinoid receptor-selective pathway

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10085968

    Multicyclic compounds and methods of use thereof

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10080740

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10071976

    Small molecule fatty acid synthase inhibitors

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10047104

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10004702

    Linear guanidine derivatives, methods of preparation and uses thereof

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9987253

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9969719

    Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9951041

    Crystalline C21H22Cl2N4O2 malonate

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9944603

    Compounds and methods for the treatment of cystic fibrosis

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9937155

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9926315

    Triazolopyridine compounds and methods for the treatment of cystic fibrosis

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9920068

    Pyridine compounds

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9901580

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9890126

    Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9890163

    Inhibitors of protein kinases

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9877956

    Antiviral compounds and methods of use thereof

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9879032

    Pyridine compounds

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9861621

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9856260

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9856264

    Isoquinolinesulfonyl derivative as RHO kinase inhibitor

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9856262

    Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9855249

    Isoxazole compounds and methods for the treatment of cystic fibrosis

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9856238

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9839624

    Flavonoid compositions and methods of use

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9833471

    Hypochlorous acid-based hand sanitizer

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9833406

    Lubricant formulations

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9822117

    Pyridoindolobenz[b,d]azepine derivatives and uses thereof

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9815825

    Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.